LTZ Therapeutics Employee Directory

Q: What is LTZ Therapeutics known for?

LTZ Therapeutics was founded in 2022. LTZ Therapeutics operates in the Biotechnology Research industry.

Q: How many employees does LTZ Therapeutics have currently?

LTZ Therapeutics has approximately 43 employees.

Q: Who are LTZ Therapeutics's key employees and leadership?

LTZ Therapeutics's key employees include: Ceo: P. R., Vice President Of Preclinical Development: S. K..

Biotechnology ResearchCalifornia, United States11-50 Employees

LTZ Therapeutics is an immunotherapy-focused global biotech company pursuing innovative therapies in oncology and autoimmune diseases. Pioneering a novel myeloid engager platform that is guided by reverse translational science, emerging disease biology, and leveraging the power of myeloid cell subsets, particularly macrophages, which offer tremendous potential as an effective therapy to improve the lives of patients with the bold aim to one day eliminate cancer.

Find LTZ Therapeutics employees' phone numbers or email addresses

LTZ Therapeutics Global Highlights

North America
29

United States Of America
29

Asia
12

China
11
Iran
1

Europe
3

Germany
3

LTZ Therapeutics's Leadership

P. R.
Ceo
Mobile Phone
Email
S. K.
Vice President Of Preclinical Development
Mobile Phone
Email
M. T.
Co-Founding Cso And Member Of The Board
Mobile Phone
Email
J. Z.
Svp And Co-Founder
Mobile Phone
Email
D. T.
Director, Clinical Biomarkers
Mobile Phone
Email
N. B.
Senior Research Associate
Mobile Phone
Email
P. Y.
Principal Scientist
Mobile Phone
Email
G. C.
Scientific Advisory Board
Mobile Phone
Email

LTZ Therapeutics Employee Metrics

100%

50%

2026

2025

Biotechnology
Business
Consultant
Human Resources
Business Development
Other

Contact profiles from LTZ Therapeutics

Name

Title

Contact Info

Location

Last Update

M. T.
Co-Founding Cso And Member Of The Board
Mobile Phone
Email
GermanyBaden-Württemberg
Jul 31, 2025
J. Z.
Svp And Co-Founder
Mobile Phone
Email
Bay
Dec 12, 2025
P. R.
Ceo
Mobile Phone
Email
United StatesGeorgia
Feb 18, 2026
S. K.
Vice President Of Preclinical Development
Mobile Phone
Email
Aug 15, 2024
D. T.
Director, Clinical Biomarkers
Mobile Phone
Email
United States
Feb 13, 2026
N. B.
Senior Research Associate
Mobile Phone
Email
Bay
Dec 12, 2025
P. Y.
Principal Scientist
Mobile Phone
Email
United States
Dec 12, 2025
G. C.
Scientific Advisory Board
Mobile Phone
Email
United StatesMichigan
Feb 17, 2026

Frequently Asked Questions

What is LTZ Therapeutics known for?

LTZ Therapeutics was founded in 2022 operates in the Biotechnology Research industry. The company's main headquarters is located in Redwood City, California 94065 United States. Explore LTZ Therapeutics's company overview page for more information.

What is LTZ Therapeutics's most common email format?

LTZ Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more LTZ Therapeutics email formats with LeadIQ.

How many employees does LTZ Therapeutics have currently?

LTZ Therapeutics has approximately 43 employees as of March 2026. These team members are located across 3 continents, including North AmericaAsiaEurope.

Who are LTZ Therapeutics's key employees and leadership?

As of March 2026, LTZ Therapeutics's key employees include:

Ceo: P. R.
Vice President Of Preclinical Development: S. K.
Co-Founding Cso And Member Of The Board: M. T.
Svp And Co-Founder: J. Z.
Director, Clinical Biomarkers: D. T.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.